Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 192 entries
Sorted by: Best Match Show Resources per page
Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications

community settings

Cookson MS, Fleshner NE.
GSID: xMur-aJuGXkJ
MS Cookson, NE Fleshner, SM Soloway… - The Journal of …, 1997 - auajournals.org

Purpose: Despite the reliability of Gleason grading with respect to the same specimen, the correlation between the biopsy and prostatectomy specimen is less well defined. We …

Cite
Cookson, M. S., Fleshner, N. E., Soloway, S. M., & Fair, W. R. (1997). Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. The Journal of urology, 157(2), 559-562.
Cookson, Michael S., et al. "Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications." The Journal of urology 157.2 (1997): 559-562.
Copy Download .nbib Format: MLA
Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Eapen LJ, Jones E, Kassouf W, Lambert C, Morgan SC, Moussa M, Nam R, Parliament M, Russell L, Saad F, Siemens DR, Souhami L, Szumacher E, Tyldesley S, Xu Y, Zbieranowski I, Breau RH, Belanger E, Black P, Estey E, Bowan J, Bora B, Brundage M, Chung P, Fleshner N, Evans A, Bauman G, Izawa J, Davidson C, Brimo F.
PMID: 27217852
Can Urol Assoc J. 2016 Mar-Apr;10(3):90-4. doi: 10.5489/cuaj.3456.

INTRODUCTION: We aimed to enumerate the rate of pelvic recurrence following radical cystectomy at university-affiliated hospitals in Canada.METHODS: Canadian, university-affiliated hospitals were invited to participate. They were asked to identify the first 10 consecutive patients undergoing radical cystectomy starting...

Cite
Eapen LJ, Jones E, Kassouf W, et al. Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. Can Urol Assoc J. 2016;10(3):90-4doi: 10.5489/cuaj.3456.
Eapen, L. J., Jones, E., Kassouf, W., Lambert, C., Morgan, S. C., Moussa, M., Nam, R., Parliament, M., Russell, L., Saad, F., Siemens, D. R., Souhami, L., Szumacher, E., Tyldesley, S., Xu, Y., Zbieranowski, I., Breau, R. H., Belanger, E., Black, P., Estey, E., Bowan, J., Bora, B., Brundage, M., Chung, P., Fleshner, N., Evans, A., Bauman, G., Izawa, J., Davidson, C., & Brimo, F. (2016). Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10(3), 90-4. https://doi.org/10.5489/cuaj.3456
Eapen, Libni J, et al. "Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 10,3 (2016): 90-4. doi: https://doi.org/10.5489/cuaj.3456
Eapen LJ, Jones E, Kassouf W, Lambert C, Morgan SC, Moussa M, Nam R, Parliament M, Russell L, Saad F, Siemens DR, Souhami L, Szumacher E, Tyldesley S, Xu Y, Zbieranowski I, Breau RH, Belanger E, Black P, Estey E, Bowan J, Bora B, Brundage M, Chung P, Fleshner N, Evans A, Bauman G, Izawa J, Davidson C, Brimo F. Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study. Can Urol Assoc J. 2016 Mar-Apr;10(3):90-4. doi: 10.5489/cuaj.3456. PMID: 27217852; PMCID: PMC4840007.
Copy Download .nbib Format: NLM
Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi B, Leao R, Nayan M, Mohammed A, Fleshner NE, Kulkarni GS.
PMID: 29485035
Can Urol Assoc J. 2018 Jun;12(6):203-210. doi: 10.5489/cuaj.4870. Epub 2018 Feb 23.

INTRODUCTION: Non-muscle-invasive bladder cancer (NMIBC) accounts for 75-85% of all urothelial bladder cancers (UBC). Many UBC patients are also afflicted by diabetes mellitus (DM). It has been postulated that several oral hypoglycemic agents could impact disease-specific survival (DSS), but...

Cite
Richard PO, Ahmad AE, Bashir S, et al. Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Can Urol Assoc J. 2018;12(6):203-210doi: 10.5489/cuaj.4870.
Richard, P. O., Ahmad, A. E., Bashir, S., Zlotta, A., Bhindi, B., Leao, R., Nayan, M., Mohammed, A., Fleshner, N. E., & Kulkarni, G. S. (2018). Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 12(6), 203-210. https://doi.org/10.5489/cuaj.4870
Richard, Patrick O, et al. "Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 12,6 (2018): 203-210. doi: https://doi.org/10.5489/cuaj.4870
Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi B, Leao R, Nayan M, Mohammed A, Fleshner NE, Kulkarni GS. Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Can Urol Assoc J. 2018 Jun;12(6):203-210. doi: 10.5489/cuaj.4870. Epub 2018 Feb 23. PMID: 29485035; PMCID: PMC5994977.
Copy Download .nbib Format: NLM
Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor.

Frontiers in psychiatry

Greenwood BN, Thompson RS, Opp MR, Fleshner M.
PMID: 25368585
Front Psychiatry. 2014 Oct 20;5:146. doi: 10.3389/fpsyt.2014.00146. eCollection 2014.

Repeated stressor exposure can sensitize physiological responses to novel stressors and facilitate the development of stress-related psychiatric disorders including anxiety. Disruptions in diurnal rhythms of sleep-wake behavior accompany stress-related psychiatric disorders and could contribute to their development. Complex stressors...

Cite
Greenwood BN, Thompson RS, Opp MR, et al. Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor. Front Psychiatry. 2014;5:146doi: 10.3389/fpsyt.2014.00146.
Greenwood, B. N., Thompson, R. S., Opp, M. R., & Fleshner, M. (2014). Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor. Frontiers in psychiatry, 5146. https://doi.org/10.3389/fpsyt.2014.00146
Greenwood, Benjamin N, et al. "Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor." Frontiers in psychiatry vol. 5 (2014): 146. doi: https://doi.org/10.3389/fpsyt.2014.00146
Greenwood BN, Thompson RS, Opp MR, Fleshner M. Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor. Front Psychiatry. 2014 Oct 20;5:146. doi: 10.3389/fpsyt.2014.00146. eCollection 2014. PMID: 25368585; PMCID: PMC4202708.
Copy Download .nbib Format: NLM
The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro.

Lipid insights

Mora BC, Fleshner NE, Klotz LH, Venkateswaran V.
PMID: 25987846
Lipid Insights. 2015 Apr 19;8:11-9. doi: 10.4137/LPI.S23135. eCollection 2015.

We examined whether serum from obese, compared to non-obese, PCa (prostate cancer) patients creates a growth-enhancing tumor micro-environment in vitro. Serum from 80 subjects was divided into four groups: normal weight men with and without PCa and overweight/obese men...

Cite
Mora BC, Fleshner NE, Klotz LH, et al. The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro. Lipid Insights. 2015;8:11-9doi: 10.4137/LPI.S23135.
Mora, B. C., Fleshner, N. E., Klotz, L. H., & Venkateswaran, V. (2015). The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro. Lipid insights, 811-9. https://doi.org/10.4137/LPI.S23135
Mora, Benjamin C, et al. "The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro." Lipid insights vol. 8 (2015): 11-9. doi: https://doi.org/10.4137/LPI.S23135
Mora BC, Fleshner NE, Klotz LH, Venkateswaran V. The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro. Lipid Insights. 2015 Apr 19;8:11-9. doi: 10.4137/LPI.S23135. eCollection 2015. PMID: 25987846; PMCID: PMC4404997.
Copy Download .nbib Format: NLM
Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Edwan GA, Ghai S, Margel D, Kulkarni G, Hamilton R, Toi A, Haidar MA, Finelli A, Fleshner NE.
PMID: 26029293
Can Urol Assoc J. 2015 May-Jun;9(5):E267-72. doi: 10.5489/cuaj.2562.

INTRODUCTION: Clinical confusion continues to exist regarding the underestimation of cancers among patients on active surveillance and among men with repeated negative prostate biopsies despite worrisome prostate-specific antigen (PSA) levels. We have previously described our initial experience with magnetic...

Cite
Edwan GA, Ghai S, Margel D, et al. Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights. Can Urol Assoc J. 2015;9(5):E267-72doi: 10.5489/cuaj.2562.
Edwan, G. A., Ghai, S., Margel, D., Kulkarni, G., Hamilton, R., Toi, A., Haidar, M. A., Finelli, A., & Fleshner, N. E. (2015). Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 9(5), E267-72. https://doi.org/10.5489/cuaj.2562
Edwan, Ghazi Al, et al. "Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 9,5 (2015): E267-72. doi: https://doi.org/10.5489/cuaj.2562
Edwan GA, Ghai S, Margel D, Kulkarni G, Hamilton R, Toi A, Haidar MA, Finelli A, Fleshner NE. Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights. Can Urol Assoc J. 2015 May-Jun;9(5):E267-72. doi: 10.5489/cuaj.2562. PMID: 26029293; PMCID: PMC4439222.
Copy Download .nbib Format: NLM
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.

Urology annals

Alkhateeb SS, Neill M, Bar-Moshe S, Rhijn BV, Kakiashvili DM, Fleshner N, Jewett M, Petein M, Schulman C, Hanna S, Bostrom PJ, Roumeguere T, Shariat SF, Rorive S, Zlotta AR.
PMID: 21976923
Urol Ann. 2011 Sep;3(3):119-26. doi: 10.4103/0974-7796.84954.

BACKGROUND AND OBJECTIVES: To evaluate the long-term prognostic value of the combination of the EORTC risk calculator and proapoptotic, antiapoptotic, proliferation, and invasiveness molecular markers in predicting the outcome of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) treated with...

Cite
Alkhateeb SS, Neill M, Bar-Moshe S, et al. Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin. Urol Ann. 2011;3(3):119-26doi: 10.4103/0974-7796.84954.
Alkhateeb, S. S., Neill, M., Bar-Moshe, S., Rhijn, B. V., Kakiashvili, D. M., Fleshner, N., Jewett, M., Petein, M., Schulman, C., Hanna, S., Bostrom, P. J., Roumeguere, T., Shariat, S. F., Rorive, S., & Zlotta, A. R. (2011). Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin. Urology annals, 3(3), 119-26. https://doi.org/10.4103/0974-7796.84954
Alkhateeb, Sultan S, et al. "Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin." Urology annals vol. 3,3 (2011): 119-26. doi: https://doi.org/10.4103/0974-7796.84954
Alkhateeb SS, Neill M, Bar-Moshe S, Rhijn BV, Kakiashvili DM, Fleshner N, Jewett M, Petein M, Schulman C, Hanna S, Bostrom PJ, Roumeguere T, Shariat SF, Rorive S, Zlotta AR. Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin. Urol Ann. 2011 Sep;3(3):119-26. doi: 10.4103/0974-7796.84954. PMID: 21976923; PMCID: PMC3183702.
Copy Download .nbib Format: NLM
Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus.

Frontiers in behavioral neuroscience

Loughridge AB, Greenwood BN, Day HE, McQueen MB, Fleshner M.
PMID: 23717271
Front Behav Neurosci. 2013 May 10;7:37. doi: 10.3389/fnbeh.2013.00037. eCollection 2013.

Serotonin (5-HT) is implicated in the development of stress-related mood disorders in humans. Physical activity reduces the risk of developing stress-related mood disorders, such as depression and anxiety. In rats, 6 weeks of wheel running protects against stress-induced behaviors...

Cite
Loughridge AB, Greenwood BN, Day HE, et al. Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus. Front Behav Neurosci. 2013;7:37doi: 10.3389/fnbeh.2013.00037.
Loughridge, A. B., Greenwood, B. N., Day, H. E., McQueen, M. B., & Fleshner, M. (2013). Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus. Frontiers in behavioral neuroscience, 737. https://doi.org/10.3389/fnbeh.2013.00037
Loughridge, Alice B, et al. "Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus." Frontiers in behavioral neuroscience vol. 7 (2013): 37. doi: https://doi.org/10.3389/fnbeh.2013.00037
Loughridge AB, Greenwood BN, Day HE, McQueen MB, Fleshner M. Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus. Front Behav Neurosci. 2013 May 10;7:37. doi: 10.3389/fnbeh.2013.00037. eCollection 2013. PMID: 23717271; PMCID: PMC3650681.
Copy Download .nbib Format: NLM
Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

Journal of cutaneous medicine and surgery

Weizman AV, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, Ippoliti A, Panikkath D, Vasiliauskas E, Shih D, McGovern DP, Melmed GY.
PMID: 25277124
J Cutan Med Surg. 2014 Oct;18(5):361.

BACKGROUND: Pyoderma gangrenosum (PG) is a severe extraintestinal manifestation of inflammatory bowel disease (IBD).OBJECTIVE: To better characterize PG features and management among an IBD cohort.METHODS: Subjects with PG were identified using a large database at a tertiary center. Patient...

Cite
Weizman AV, Huang B, Targan S, et al. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. J Cutan Med Surg. 2014;18(5):361
Weizman, A. V., Huang, B., Targan, S., Dubinsky, M., Fleshner, P., Kaur, M., Ippoliti, A., Panikkath, D., Vasiliauskas, E., Shih, D., McGovern, D. P., & Melmed, G. Y. (2014). Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. Journal of cutaneous medicine and surgery, 18(5), 361.
Weizman, Adam V, et al. "Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study." Journal of cutaneous medicine and surgery vol. 18,5 (2014): 361.
Weizman AV, Huang B, Targan S, Dubinsky M, Fleshner P, Kaur M, Ippoliti A, Panikkath D, Vasiliauskas E, Shih D, McGovern DP, Melmed GY. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study. J Cutan Med Surg. 2014 Oct;18(5):361. PMID: 25277124; PMCID: PMC5089702.
Copy Download .nbib Format: NLM
Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis.

Oncotarget

Goldberg H, Klaassen Z, Chandrasekar T, Sayyid R, Kulkarni GS, Hamilton RJ, Fleshner NE.
PMID: 29721162
Oncotarget. 2018 Apr 10;9(27):18797-18810. doi: 10.18632/oncotarget.24694. eCollection 2018 Apr 10.

OBJECTIVES: To evaluate the utilization and outcomes of perioperative chemotherapy in non-metastatic UTUC patients over the past decade using a large national database.METHODS: All patients aged 18 and older diagnosed with non-metastatic UTUC between 2004 and 2013 were identified...

Cite
Goldberg H, Klaassen Z, Chandrasekar T, et al. Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis. Oncotarget. 2018;9(27):18797-18810doi: 10.18632/oncotarget.24694.
Goldberg, H., Klaassen, Z., Chandrasekar, T., Sayyid, R., Kulkarni, G. S., Hamilton, R. J., & Fleshner, N. E. (2018). Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis. Oncotarget, 9(27), 18797-18810. https://doi.org/10.18632/oncotarget.24694
Goldberg, Hanan, et al. "Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis." Oncotarget vol. 9,27 (2018): 18797-18810. doi: https://doi.org/10.18632/oncotarget.24694
Goldberg H, Klaassen Z, Chandrasekar T, Sayyid R, Kulkarni GS, Hamilton RJ, Fleshner NE. Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis. Oncotarget. 2018 Apr 10;9(27):18797-18810. doi: 10.18632/oncotarget.24694. eCollection 2018 Apr 10. PMID: 29721162; PMCID: PMC5922356.
Copy Download .nbib Format: NLM
Oral contraceptive use is associated with prostate cancer: an ecological study.

BMJ open

Margel D, Fleshner NE.
PMID: 22102643
BMJ Open. 2011 Nov 14;1(2):e000311. doi: 10.1136/bmjopen-2011-000311. Print 2011.

Background Several recent studies have suggested that oestrogen exposure may increase the risk of prostate cancer (PCa). Objectives To examine associations between PCa incidence and mortality and population-based use of oral contraceptives (OCs). It was hypothesised that OC by-products...

Cite
Margel D, Fleshner NE. Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ Open. 2011;1(2):e000311doi: 10.1136/bmjopen-2011-000311.
Margel, D., & Fleshner, N. E. (2011). Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ open, 1(2), e000311. https://doi.org/10.1136/bmjopen-2011-000311
Margel, David, and Fleshner, Neil E. "Oral contraceptive use is associated with prostate cancer: an ecological study." BMJ open vol. 1,2 (2011): e000311. doi: https://doi.org/10.1136/bmjopen-2011-000311
Margel D, Fleshner NE. Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ Open. 2011 Nov 14;1(2):e000311. doi: 10.1136/bmjopen-2011-000311. Print 2011. PMID: 22102643; PMCID: PMC3221291.
Copy Download .nbib Format: NLM
Reply by Authors.

The Journal of urology

Wang WW, Sorokin I, Aleksic I, Fisher H, Kaufman RP, Winer A, McNeill B, Gupta R, Tilki D, Fleshner N, Klotz L, DiRienzo AG, Tenniswood M.
PMID: 32579041
J Urol. 2020 Sep;204(3):475. doi: 10.1097/JU.0000000000001020.02. Epub 2020 Jul 23.

No abstract available.

Cite
Wang WW, Sorokin I, Aleksic I, et al. Reply by Authors. J Urol. 2020;204(3):475doi: 10.1097/JU.0000000000001020.02.
Wang, W. W., Sorokin, I., Aleksic, I., Fisher, H., Kaufman, R. P., Winer, A., McNeill, B., Gupta, R., Tilki, D., Fleshner, N., Klotz, L., DiRienzo, A. G., & Tenniswood, M. (2020). Reply by Authors. The Journal of urology, 204(3), 475. https://doi.org/10.1097/JU.0000000000001020.02
Wang, Wei-Lin Winnie, et al. "Reply by Authors." The Journal of urology vol. 204,3 (2020): 475. doi: https://doi.org/10.1097/JU.0000000000001020.02
Wang WW, Sorokin I, Aleksic I, Fisher H, Kaufman RP, Winer A, McNeill B, Gupta R, Tilki D, Fleshner N, Klotz L, DiRienzo AG, Tenniswood M. Reply by Authors. J Urol. 2020 Sep;204(3):475. doi: 10.1097/JU.0000000000001020.02. Epub 2020 Jul 23. PMID: 32579041.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 192 entries